Skip to main content

Accessibility Tools

Breaking News: Myonex appoints Greg Lavin as Chief Executive Officer as James Lovett retires, joins Board of Directors

Debbie Mohollen

Chief Financial Officer

Debra is responsible for the overall financial strategy and direction at Myonex. A pharmaceutical and biotechnology industry and a seasoned finance leader, she joined the company in 2025 as Vice President, Accounting and Finance, building on 25 years of experience building teams, implementing systems and driving growth in the life sciences sector. Prior to joining Myonex, she held financial leadership positions with Marinus Pharmaceuticals, a biotech company purchased by Immedica Pharma; Idera Pharmaceuticals, an early-stage biotech specializing in rare diseases; and Viropharma Incorporated, a global biotech; and she also managed an IPO for Houghton International, a family-owned, PE-backed global chemical manufacturer. She holds a B.S. in Accounting from Ursinus College and a Master of Leaderships Development from Penn State University. She has also been a panelist speaking on cybersecurity and ransomware.